Research

Dr. Luttrull has been active throughout his career in research, presenting papers and lectures to ophthalmology societies and publishing original articles in peer review journals, including Journal of Organic Chemistry, Heterocyclic Chemistry, Retina, Ophthalmology, Western Journal of Medicine,  American Journal of Ophthalmology, Archives of Ophthalmology, Eye,  British Journal of Ophthalmology, Expert Reviews in Ophthalmology, and Investigative Ophthalmology and Visual Science. He has written invitational monographs on his original research in magazines for retina specialists including Retinal Physician and Retina Today. He frequently serves as a scientific reviewer for a number of ophthalmic peer review journals.

•

Dr Luttrull's publications, often in collaboration with international experts, have dealt with rare and obscure diseases such as Acute Retinal Pigment Epitheliitis, to problems of local Southern California interest such as “Surfing Related Ocular Injuries”.  However, Dr. Luttrull’s primary research interests have been directed toward improving treatment of common and potentially blinding eye diseases. Of particular note is his development of the "Pneumatically Stented Implant" (PSI) procedure, a novel surgical technique for  vision-preserving treatment of the most complicated forms of glaucoma such as diabetic neovascular  glaucoma; and Subthreshold Diode Micropulse Photocoagulation (SDM), the first effective and completely atraumatic (safe) laser technique for the treatment of diabetic retinopathy and other retinal vascular diseases.

Patents

With colleague Robert Avery, MD, Dr. Luttrull holds three patents concerning a device and method to permit long-term delivery of  medications to the retina. This device may someday be instrumental in allowing treatment of currently untreatable blinding retinal diseases.